Cours Mind Medicine (MindMed) Inc. Other OTC
Actions
MMEDF
CA60255C1095
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | - | Capitalisation | 652 M 588 M |
---|---|---|---|---|---|
Résultat net 2024 * | -123 M -111 M | Résultat net 2025 * | -106 M -95,66 M | VE / CA 2024 * | - |
Trésorerie nette 2024 * | 185 M 167 M | Trésorerie nette 2025 * | 100 M 90,42 M | VE / CA 2025 * | - |
PER 2024 * |
-4,96
x | PER 2025 * |
-6,34
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 97,24% |
Dernier transcript sur Mind Medicine (MindMed) Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | 35 | 14/01/21 |
Miri Wernli
PSD | President | 71 | 28/02/20 |
Daniel Karlin
CTO | Chief Tech/Sci/R&D Officer | 44 | 01/02/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 65 | 29/09/21 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 11/08/22 |
David Gryska
BRD | Director/Board Member | 68 | 21/06/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+29,77% | 49,46 Md | |
+1,00% | 42,58 Md | |
+49,39% | 42,49 Md | |
-5,26% | 29,09 Md | |
+13,68% | 26,61 Md | |
-22,99% | 18,64 Md | |
+8,22% | 13,16 Md | |
+32,41% | 12,55 Md | |
+24,01% | 12,1 Md |